Bacillus subtilis B38, isolated from soil, showed antimicrobial activity against human pathogenic Candida albicans species. Specific PCR primers revealed the presence of the bamC gene, which is involved in the biosynthesis of bacillomycin D. Three anti-Candida compounds designated a 1 , a 2 and a 3 were purified from culture supernatant and identified using matrix-assisted laser desorption/ionization time-of-flight MS as analogues of bacillomycin D-like lipopeptides of 14, 15 and 16 carbon fatty acid long chains, respectively. The compound a 3 displayed the strongest fungicidal activity against pathogenic C. albicans strains. It was even more active than amphotericin B with a lethal concentration of 59.07 vs. 135.26 mM of the antimycotic drug against the pathogenic strain C. albicans sp. 311 isolated from finger nail. Only moderate or weak anti-Candida activity was recorded for a 1 and a 2 compounds. Furthermore, a 3 showed the highest hemolytic activity, reaching 50% hemolysis at 22.14 mM, whereas a 1 and a 2 displayed a limited hemolysis at 68.26 and 37.41 mM, respectively. These findings suggest that the acyl chain length of bacillomycin D-like lipopeptides plays a major role in hemolytic and antifungal activities.
Introduction
Numerous species of Candida are associated with human pathologies and their invasive infections remain major causes of morbidity and mortality, especially in immunocompromised individuals (Zarif et al., 2000) . The current treatments to defeat fungal infections are limited to some antifungal agents such as amphotericin B, nystatin and azole derivatives (Onishi et al., 2000) . However, most of these compounds are synthetic derivatives with known serious side effects and toxicity (Onishi et al., 2000) . In addition, their failure has increased because of a rapid emergence of resistant fungal pathogens (Onishi et al., 2000) . Therefore, the discovery of new antimycotic compounds from natural sources is urgently needed.
Several natural lipopeptides produced by microorganisms have been developed as new therapeutics (Pirri et al., 2009) . A common feature is the presence of an acyl chain conjugated to a linear or a cyclic peptide sequence.
The peptide portion could be composed of either anionic or cationic residues and might contain nonproteinaceous or unusual amino acids (Jerala, 2007; Strieker & Marahiel, 2009) . The lipopeptide compounds are synthesized nonribosomally by a large modular multienzyme templates designated as peptide synthetases. The ability of Bacillus sp. to synthesize a wide variety of lipopeptide antibiotics has been extensively exploited in medicine and agriculture (Moyne et al., 2001) . Among them, members of the iturin family comprising bacillomycin D, iturin and mycosubtilin are potent antifungal agents and display hemolytic and limited antibacterial activities (Maget-Dana & Peypoux, 1994) ; fengycin is endowed with a specific antifungal activity against filamentous fungi and inhibits phospholipase A 2 (Nishikori et al., 1986) ; surfactin was revealed to be an interesting peptide for clinical applications, displaying both antiviral and antimycoplasma activities beside its antifungal and antibacterial properties (Vollenbroich et al., 1997a, b) .
In a previous paper, we described the production of several antimicrobial compounds by a newly identified Bacillus subtilis B38 strain (Tabbene et al., 2009) . At least four bioactive spots were observed on thin layer chromatography (TLC) plate. Three of them exhibited antibacterial activity and only one spot displayed antifungal activity against phytopathogenic fungi. In this study, specific genes of nonribosomal peptide synthetases involved in lipopeptides biosynthesis were screened in B. subtilis B38. Three antifungal compounds exhibiting anti-Candida activity were purified to near homogeneity and biochemically characterized. The effects of these purified lipopeptides on growth inhibition of pathogenic isolates of Candida albicans as well as on human erythrocytes hemolysis were also investigated.
Materials and methods

Microorganisms and culture media
Bacillus subtilis strain B38 isolated previously from soil was cultured in trypticasein soy broth (TSB) as described previously (Tabbene et al., 2009) . Bacillus subtilis ATCC 21556, ATCC 21332, ATCC 6633 and B. subtilis 49 producing iturin, surfactin, mycosubtilin and bacillomycin D, respectively, were used as positive controls and cultured in Luria-Bertani broth.
Human pathogenic yeasts C. albicans were isolated from finger nail (FN), between fingers (BF), mouth cavity (MC), tongue (T) and vaginal cavity (VC) and cultured in Sabouraud dextrose agar plates supplemented with chloramphenicol at 25 1C.
Determination of the anti-Candida activity
The anti-Candida activity was assayed against the yeast C. albicans ATCC 10231 using the agar disk diffusion method as described previously (Naeini et al., 2009) . To determine the titer of the antifungal activity, serial twofold dilutions of the extracts were performed. The anti-Candida activity was expressed as activity units (AU) mL À1 corresponding to the reciprocal of the highest dilution causing inhibition of the yeast growth.
Molecular detection of lipopeptide nonribosomal peptide synthetase (NRPS) genes
Genomic DNA was isolated from B. subtilis B38 or the positive control strains by DNeasy blood and tissue kit (Qiagen). PCR was used to screen for the presence of NRPS genes involved in iturin, bacillomycin D and surfactin biosynthesis (Stein, 2005) . Specific primer pairs of synthetase cluster genes were used (Table 1) . PCR assay was performed as previously described (Ramarathnam et al., 2007) 
Purification of the anti-Candida compounds
Production of the antifungal compounds was performed as described previously (Tabbene et al., 2009) . Briefly, B. subtilis B38 was cultured in TSB medium at 30 1C for 24 h with constant shaking at 150 r.p.m. Cells were harvested by centrifugation at 12 000 g for 15 min and the cell-free supernatant (CFS) was filtered through 0.45-mm membranes. Extraction of the antifungal compounds from CFS was performed with methanol. After centrifugation, the supernatant was evaporated with a rotary evaporator and the dried material was dissolved in sterile deionized water. The methanolic extract was then loaded on a Sep-Pack C18 cartridge (Waters, Millipore) and elution was performed with a discontinuous gradient of acetonitrile (0%, 20%, 40%, 60% and 100%). After drying under reduced pressure (Speed-Vac, Savant), each fraction was tested for its antiCandida activity. The active fraction eluted at 40% acetonitrile (F40) was dissolved in 10 mM ammonium acetate buffer pH 7 and subjected to anion exchange chromatography (SAX cartridge). Elution was performed using a discontinuous gradient of 10 mM ammonium acetate buffer at pH 7, 6, 5, 4, 3 and then with 50% and 100% methanol. The active fraction was applied onto reversed-phase (RP)-HPLC C18 column (Discovery BioWide Pore). A linear gradient of acetonitrile (20-100%) at a flow rate of 1 mL min À1 was used. Solvent A was deionized water 10.1% trifluoroacetic acid (TFA) and solvent B was acetonitrile 10.1% TFA. Absorbance was monitored at 215 nm.
Physicochemical properties of the anti-Candida compounds
Temperature stability was evaluated by incubating the purified compounds at various temperatures from 30 to 100 1C for 30 min or at 121 1C for 20 min. Residual antiCandida activity was determined by disk diffusion assay against C. albicans. The effect of pH was determined using a pH range from 2 to 10 adjusted with diluted HCl or NaOH. After incubation for 2 h at room temperature and neutralization to pH 7, the residual activity was measured. Resistance to proteases was tested by incubating the purified compounds with proteinase K, trypsin, a-chymotrypsin and lipase A at 1 : 10 or 1 : 5 (w/w) ratios, as described previously (Tabbene et al., 2009) .
TLC analysis of the anti-Candida compounds
HPLC-purified fractions were subjected to TLC using nbutanol-methanol-water (39 : 10 : 20, v/v/v) as the mobile phase. The bioassay was performed using C. albicans ATCC 10231. TLC plates were sprayed with water for the detection of hydrophilic compounds. Spraying with ninhydrin or 4,4 0 -Bis(dimethylamino)diphenylmethane (TDM) allowed the detection of compounds with free amino groups or with peptide bonds, respectively (Yu et al., 2002) and spraying with Pauly reagent allowed the detection of tyrosine-containing peptides (Jutisz, 1960) .
Analysis of b-amino acids
Lipopeptide compounds were hydrolyzed in sealed tubes with 6 N HCl at 150 1C for 8 h. After total hydrolysis, liposoluble moieties were extracted with chloroform (Besson et al., 1976) , analyzed by TLC on a silica gel 60 plate in chloroform-methanol-water (65 : 25 : 4) and revealed with ninhydrin as described previously (Russell, 1960) .
MS analysis
HPLC-purified fractions were analyzed using matrixassisted laser desorption/ionization time-of-flight MS (MALDI-TOF/MS). Samples dissolved in methanol (1 mL) were mixed with 1 mL of matrix (a-cyano-4-hydroxycinnamic acid) at 5 mg mL À1 in 50 : 50 H 2 O : CH 3 CN containing 0.1% TFA.
Spectra were acquired using a prOTOF 2000 system (Perkin Elmer) operating in positive reflectron mode with an accelerating voltage of 16 kV.
Determination of minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC)
The MIC of the purified compounds against human isolates of the pathogen C. albicans was determined by the microbroth dilution assay. One million cells mL
À1
of C. albicans were tested for their sensitivity to twofold increasing concentrations of the compounds (from 1.95 to 1000 mg mL À1 ). Amphotericin B was used as a positive control. After incubation at 28 1C for 24 h, yeast growth was determined by measuring the OD 600 nm with a microplate reader (Bioteck, ELx 800). The MIC was defined as the lowest concentration of the compounds inhibiting the yeast growth. MFC was determined from the same experiments by removing 10 mL from wells displaying no yeast growth after 48 h of incubation. Aliquots were spread onto Sabouraud dextrose agar plates, incubated at 28 1C for 24 h and counted. MFC was defined as the lowest concentration that killed 95% of the fungal population.
Hemolytic assay
The hemolytic activity of the purified compounds on human erythrocytes was determined as reported previously (Mangoni et al., 2000) . Briefly, heparinized human blood was washed with 0.9% w/v NaCl and 5% v/v of a suspension of fresh human erythrocytes was incubated with various concentrations of the anti-Candida compounds for 30 min at 37 1C with gentle mixing. The tubes were centrifuged (600 g, 10 min) and absorbance of the supernatants was measured at 415 nm. Total hemolysis was obtained by suspending erythrocytes in deionized water.
Results and discussion
Molecular detection of NRPS lipopeptide genes
The detection of iturin A, bacillomycin D and surfactin was performed by PCR amplification of the corresponding NRPS gene cluster. A unique amplicon of 957 bp was detected with a primer pair of bamC gene, which is specifically involved in bacillomycin D synthesis but no response was obtained with specific primers of iturin, mycosubtilin and surfactin (Fig. 1) . These results suggest that the B38 strain harbor only the gene cluster of peptide synthetases required for bacillomycin D biosynthesis.
Purification of the anti-Candida compounds
The anti-Candida compounds were purified to near homogeneity from the CFS of B. subtilis B38 strain. Data of the purification steps are summarized in Table 2 and showed that methanol extraction increased the specific activity till 1200 AU mL À1 . The methanol extract was applied onto
Sep-Pak C18 cartridge and the fraction endowed with anti-Candida activity was eluted at F40. This fraction showed a specific activity of 12 000 AU mL À1 . F40 was further loaded onto SAX cartridge and eluted with methanol 50% v/v. It gave a specific activity of 20 000 AU mL À1 . The anti-Candida compounds present in the fraction were further purified by RP-HPLC using C18 column (Fig. 2) . Two anti-Candida compounds called a 1 and a 2 , which eluted at 36% and 39% acetonitrile showed specific activities of 1600 and 8000 AU mL À1 , respectively. A third compound a 3 eluted at 42% acetonitrile and exhibited the highest specific activity reaching 24 000 AU mL À1 . As determined by TLC, a 1 compound exhibited an R f of 0.53 whereas a 2 and a 3 displayed the same R f of 0.58 (Fig. 2, inset lane 1) .
Physicochemical properties of the anti-Candida compounds
The optimal temperature and pH of a 1 , a 2 and a 3 were also investigated. These compounds conserved 100% of their initial activity up to 90 1C and lost 30% of their initial activity after autoclaving at 121 1C for 20 min. They were stable in the pH range 2-10, resistant to proteases but affected by lipases. These compounds were not revealed by ninhydrin but gave a positive reaction to TDM (Fig. 2 , inset lane 2) indicating the absence of free amino groups and the presence of peptide bonds. Moreover, they were detected after treatment with 5% sulfuric acid (data not shown) or after spraying with water ( Fig. 2 , inset lane 3) suggesting their lipophilic nature (Yu et al., 2002) . The tyrosine-containing compounds were revealed with Pauly reagent (Fig. 2, inset lane 4) , whereas the b-amino fatty acids released after acid hydrolysis of bacillomycin D homologues were revealed on TLC plates with ninhydrin (Fig. 2, inset  lane 5) . These results suggest that the anti-Candida compounds belong to the iturin group characterized by the presence of tyrosine residue and a lipid-soluble b-amino fatty acid (Peypoux et al., 1981; Besson & Michel, 1986; Stein, 2005; Volpon et al., 2007) .
The molecular masses of the three lipopeptide compounds were determined by MALDI-TOF/MS. The spectrum mass of a 1 , a 2 and a 3 showed homologues (M1Na) 1 major peaks at m/z 1053.5, 1067.5 and 1081.5, respectively, suggesting that these compounds are homologue molecules exhibiting different lengths in their fatty acid chain (CH 2 = 14 Da). Moreover, the molecular masses of these anti-Candida compounds are very close to C14, C15 and C16 homologues of bacillomycin D described in previous reports (Peypoux et al., 1984; Moyne et al., 2001; Koumoutsi et al., 2004; Oleinikova et al., 2005) . These results confirmed the presence of the bamC gene involved in the synthesis of bacillomycin D in B. subtilis B38 strain.
Anti-Candida activity of the purified compounds
The MIC and MFC values of the purified compounds were evaluated against host pathogenic Candida strains and were compared with those of amphotericin B (Table 3 ). The most potent compound a 3 containing 16 carbons in its fatty acid moiety had MFC values superior to those of amphotericin B against most pathogenic C. albicans species. Furthermore, a 3 showed a twofold lower MFC value (59.07 mM) than that of amphotericin B (135.26 mM) against the pathogenic-resistant C. albicans sp. 311 FN. The compound a 2 containing 15 carbons in the fatty acid moiety exhibited a moderate antiCandida activity and was two-to eightfold less active than a 3 . Moreover, compound a 1 , having the shortest fatty acid chain (14 carbons), showed a weak anti-Candida effect and was 8-32-fold less active than a 3 . Differential sensitivity of C. albicans toward these compounds could be related to the length of the acyl chain. Our data suggest a direct correlation between the length of the acyl chain of these compounds and their anti-Candida activities. Previous reports have underlined the importance of the length of the lipid moiety of bacillomycin D and bacillopeptin lipopeptides in the inhibitory effect against various fungal species (Kajimura et al., 1995; Moyne et al., 2001) . Members of the iturin family generally exhibit strong antifungal activity against a wide variety of fungi, by interacting with the cytoplasmic membrane causing pore formation Maget-Dana & Peypoux, 1994) . It is tempting to speculate that differences in the activity of the anti-Candida compounds are related to the deepness of the generated membrane pores. In fact, antifungal compounds with a long acyl chain could be entirely incorporated into the yeast membrane compared to those having shorter acyl chains that presumably cannot span a membrane (Maget-Dana & Ptak, 1995) . Furthermore, it has been demonstrated that lipopeptides with long aliphatic chains have the tendency to form oligomers, which increase their microbicidal activity on fungal cells (Avrahami & Shai, 2004; Malina & Shai, 2005) . The relative lower anti-Candida activity of the shorter lipopeptides could be related to their reduced ability to permeate fungal membranes, because of their low hydrophobic character to drive oligomerization (Malina & Shai, 2005) .
Hemolytic activity
The effect of various concentrations of the purified antiCandida compounds on human erythrocytes is reported in Table 4 . The compound a 1 showed a weak hemolytic activity (50% hemolysis at 68.26 mM) compared with a 2 and a 3 (50% hemolysis at 37.41 and 22.14 mM, respectively). This could be due to their low hydrophobicity, and therefore, limited ability to oligomerize, which is an important requirement for both the hemolytic and antifungal activity of an antimicrobial peptide. Prior studies showed a direct correlation between the fatty acid chain length of surfactin lipopeptides and hemolytic activity (Kracht et al., 1999) . It is noticeable that the hemolytic activity of the lipopeptide bacircines is also dependent on the length of the aliphatic side chain and that hemolysis is provoked by the insertion of the fatty acid chain into the phospholipid bilayer (Prokof'eva et al., 1999) . Similarly, iturins A are able to lyse human erythrocytes in a dose-dependent manner (100% hemolysis at 25 mM) (Quentin et al., 1982; Aranda et al., 2005) . This limits their potential usage in clinical therapy Aranda et al., 2005; Oleinikova et al., 2005; Ramarathnam et al., 2007; Chen et al., 2009) . Nevertheless, we found that compound a 3 with a long fatty acid chain exhibited a strong inhibitory effect (MFC value between 7.38 and 14.76 mM) against most tested strains of C. albicans causing mucous and cutaneous infections. Note that at these concentrations a 3 compound showed a reduced hemolytic activity (17% and 35%). However, when tested against some pathogenic C. albicans strains causing finger nail candidiasis (C. albicans sp. 265 FN and C. albicans sp. 311 FN), compound a 3 exhibited both higher MFC values (between 29.53 and 59.07 mM) and hemolytic activity (between 65.91% and 99.64%). Overall, for the treatment of such pathogenic strains causing cutaneous candidiasis, a local application of the a 3 compound rather than a systemic or an oral administration is possible.
In conclusion, our data have indicated that B. subtilis produce anti-Candida lipopeptides that might be used to treat cutaneous infections. 
